Folgen

  • 238: How Do We Know AI Is Ready for Pathology

    238: How Do We Know AI Is Ready for Pathology
    May 19 2026
    Send us Fan MailDo you really need a scanner, whole slide images, and AI infrastructure before you can start in digital pathology?In this episode, I argue that you do not.I’m Dr. Aleksandra Zuraw, veterinary pathologist and digital pathology educator, and this talk is about a belief I hear all the time: I don’t have the tools yet, so there is no point learning digital pathology. I used to think that too. When I was training in Berlin, there was one Leica 6-slide scanner, and it felt like digital pathology was only for a small group of chosen people. That experience made the field feel distant, exclusive, and not really available to beginners. What changed for me was not a new scanner. It was a small project.I needed a more consistent way to quantify a senescence marker in archived skin samples, so I used a microscope camera, captured images, opened them in Microsoft Paint, and manually marked cells with colored dots. It was scrappy. Very low tech. But it was also digital, consistent, and verifiable. That project became my first real step into digital pathology and helped me get my first job in the field, where I worked between pathologists and image analysis scientists on biomarker quantification and patient stratification problems. That is the core point of this episode: knowledge unlocks technology.Scanners matter. AI tools matter. But the deeper bottleneck is whether enough people understand how to use these tools, ask good questions, and connect pathology expertise with digital workflows. That is why this episode is really about readiness. Not readiness of the hardware. Readiness of the people.I also talk about Dr. Taladzer from Pakistan, whose story makes this point even more clearly. At the time, Pakistan had around 220 million people, about 500 pathologists, and zero scanners. She still started learning digital pathology during COVID using a microscope and camera, joined the Digital Pathology Association, taught herself from papers and online resources, and kept going even after multiple AI vendors rejected her because she did not have whole slide images. Eventually, she found a DIY image analysis platform, learned to annotate and train models on static images, completed projects quickly, and went on to publish more than 10 digital pathology papers without ever using WSI.Why should you listen?Because this episode is for pathologists and lab leaders who are interested in digital pathology but still feel stuck at the beginning. It is for people waiting for permission, perfect infrastructure, or a formal roadmap. And it is for trailblazers who came back from a meeting or conference energized, but need a practical way to turn that energy into action before it fades.I also address an important AI question near the end: How do we know an AI model is good enough for pathology? I talk about why models are only as good as the pathologist annotations used to train them, why concordance between pathologists matters, how orthogonal labels like IHC can improve model quality, and why pathologists still need to stay in the loop as these systems develop and get deployed.If you are trying to figure out where to start, this episode gives you a practical answer: start where you are. Start with what you have. Start learning now.Episode Highlights00:00 – Why the real barrier to digital pathology is usually not the hardware 00:33 – What it feels like to be at the beginning of the digital pathology journey 02:50 – My first practical digital pathology project using a microscope camera and Microsoft Paint 05:37 – How that low-tech project led to my first digital pathology job 08:52 – Why knowledge, not infrastructure, is the real unlock 09:57 – Dr. Taladzer’s story: starting digital pathology in Pakistan with zero scanners 12:03 – What happened after repeated vendor rejection and why persistence mattered 14:39 – The “forgetting loop” vs the “commitment loop” after conferences 16:48 – Practical next steps: book, PubMed alerts, journal clubs, webinars, vendor resources 18:52 – Why I believe digital pathology is the gateway to faster diagnosis 20:00 – How to think about whether an AI model is really ready for pathologyResources MentionedDigital Pathology 101 – free book recommended as a starting point for learning digital pathology. Digital Pathology Association – mentioned as a learning resource and professional community. PubMed alerts for AI and digital pathology. Journal clubs – mentioned as one way to keep learning consistently. Webinars and vendor resources – suggested as practical ways to keep building knowledge. A4A – the DIY image analysis platform that supported Dr. Taladzer’s early work with static image annotation and model training. Support the showGet the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    20 Min.
  • 237: Why Pathology Vendor's Don't Speak the Same Language?

    237: Why Pathology Vendor's Don't Speak the Same Language?
    May 18 2026
    Send us Fan MailWhy are pathology vendors still speaking different image languages when radiology solved that problem decades ago?In this episode of DigiPath Digest #46, I talk through four papers that all point to a bigger issue in digital pathology: we are not only dealing with better algorithms. We are dealing with interoperability, workflow design, explainability, and whether the field is actually ready to use these tools well.I start with DICOM in digital pathology, because I think this is still one of the most important infrastructure questions in the field. Digital pathology has clear value for consultation, image analysis, archival, and workflow, but vendor-specific whole slide image formats still create silos. In the episode, I explain why DICOM matters, why adoption is still low, how the multi-resolution pyramid works, and why this is really about enterprise imaging and future-proofing, not just file conversion. Then I move into kidney transplant rejection, where the paper makes a strong case for multimodal precision diagnostics. Creatinine is late. Antibody testing can miss important biology. Biopsies can miss the area that matters. So the opportunity is not to replace pathology, but to combine biomarkers, biopsy, and machine learning in a way that is more useful than any one signal alone. I also talk about explainability here, because if a model gives a risk score, we need to know what contributed to it. The third paper focuses on perineural invasion in solid tumors, and I liked this one a lot because it shows how AI can help standardize something that is clinically important but still inconsistently detected and reported. Perineural invasion is not just a passive pathway of spread. The biology is more active than that, and the quantification can go far beyond a simple yes-or-no answer. This is a good example of where digital pathology can do something humans cannot realistically do by eye at scale. The last paper is on gastric cancer immunohistochemistry biomarkers and advanced quantification, including HER2, PD-L1, mismatch repair, and CLDN18.2. This section is really about complexity. We are now asking pathologists to visually score biology that is getting harder and harder to summarize consistently, especially when markers, spatial context, and multiplexing all start to matter at once. I make the case that computational pathology is becoming necessary here, not because pathologists are failing, but because the biology is outgrowing purely visual workflows. What ties these four papers together is simple: digital pathology is not only about remote reading anymore. It is about interoperability, quantification, explainable AI, and making pathology more precise in places where the old workflow is reaching its limit. If you are a pathologist, lab leader, or digital pathology trailblazer trying to figure out what actually matters right now, this episode will help you connect the dots.Episode Highlights 07:41 – Why DICOM still matters if we want digital pathology systems to work together. 14:39 – Current adoption of SVS, MRXS, and DICOM, and why DICOM is still lagging. 16:44 – How the DICOM whole slide image pyramid works and why it matters for workflow. 24:29 – Why kidney transplant rejection is still difficult to diagnose with any single marker. 29:18 – Why perineural invasion is clinically important and still inconsistently reported. 34:44 – How AI can quantify tumor-nerve relationships more consistently than visual review alone. 46:39 – Why gastric cancer biomarker scoring is getting too complex for purely visual workflows. 54:55 – Multiplexing, spatial biology, and why explainable AI matters in biomarker interpretation. 01:04:01 – What is really blocking digital pathology adoption: cost, workflow, regulation, or mindset? Resources mentionedDICOM / digital pathology interoperability paper https://pubmed.ncbi.nlm.nih.gov/42093730/Kidney transplant rejection, biomarkers, and artificial intelligence https://pubmed.ncbi.nlm.nih.gov/42073482/Perineural invasion in solid tumors with AI and machine learning applications https://pubmed.ncbi.nlm.nih.gov/42100436/Gastric cancer IHC biomarkers, advanced detection methods, and perspectives https://pubmed.ncbi.nlm.nih.gov/42075555/Digital Pathology Place https://digitalpathologyplace.comDigital Pathology 101 Free PDF book mentioned at the end of the episode through Digital Pathology Place.Support the showGet the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    33 Min.
  • 236: What Happens When a Patient Sees Their Cancer for the First Time | Podcast with Michele Mitchell

    236: What Happens When a Patient Sees Their Cancer for the First Time | Podcast with Michele Mitchell
    May 15 2026
    Send us Fan MailWhat if the most frightening part of a pathology report is not the word cancer, but the silence that follows?In this episode of the Digital Pathology Podcast, Dr. Aleksandra Zuraw talks with Michele Mitchell—breast cancer survivor, caregiver, national patient advocate, and longtime volunteer across Michigan Medicine, ASCP, the Digital Pathology Association, and MyPathologyReport.ca—about what happened when she saw her own cancer slide years after treatment. That moment changed how she understood her disease, her risk, and her role as a patient advocate.This is not just a patient story. It is a digital pathology implementation story.The episode looks at how digital pathology removes practical barriers to sharing slides, why pathology clinics matter, and what becomes possible when pathologists move from being hidden in the background to becoming direct contributors to patient understanding. Michelle and Dr. Aleks talk through the communication gap around pathology reports, the emotional cost of delayed explanation, and the real-world workflow of pathology clinic visits built to help patients review their slides with the pathologist who made the diagnosis.They also discuss what the 21st Century Cures Act changed for patients, why immediate access to reports without interpretation can still create fear, and how pathology clinics can bridge the gap between raw data and real understanding. The conversation gets practical too: how patients can request a pathology clinic visit, what virtual pathology consults can look like, how billing and workflow concerns are already being addressed, and why the infrastructure question is smaller than many people assume.If you work in digital pathology, pathology informatics, patient communication, or implementation, this episode is a reminder that visibility is not extra. It is part of the value proposition. And for pathologists who worry this is too far outside the traditional role, the episode offers a grounded counterpoint: the workflows, templates, billing structures, and virtual options already exist.Highlights00:00 – Why pathology needs to become more patient-centered Michele frames the core problem clearly: what often scares patients is not only cancer, but the silence around the diagnosis. 00:34 – How digital pathology changes the patient experience Digital slides make it possible for patients to see their diagnosis, compare normal and abnormal tissue, and ask better questions. 11:13 – What happened when Michele saw her cancer for the first time More than a decade after treatment, seeing her own slide changed how she understood her grade, her risk, and her daily health decisions. 16:19 – Why visual pathology can change adherence and lifestyle Michele explains how the image-based explanation became a practical turning point, not just an emotional one. 20:43 – The case for direct pathologist-patient communication The episode reviews why this can improve clarity, treatment understanding, clinic efficiency, and even professional satisfaction for pathologists. 38:40 – What a pathology clinic actually looks like From preparation and consent to slide review, plain language, empathy, and follow-up, the workflow is much more concrete than many people assume. 45:35 – ASCP’s certification workshop for pathology clinics Michele describes the national effort to make pathology clinics reproducible, scalable, and easier to implement. 49:32 – What the 21st Century Cures Act changed Patients now get near real-time access to reports, but that access still needs interpretation, context, and support. 01:03:23 – Pushback, logistics, and why the barriers are not where people think Time, reimbursement, scheduling, and virtual setup are addressed directly with examples already in practice. 01:16:57 – The future: patient-friendly reports, AI, and pathology as part of the care team The episode closes on a practical vision: not hype, but tools and workflows that already exist and can be connected now. Resources mentionedDigital Pathology Place – website and educational platform referenced by Dr. Aleks as the home for her work and resources. Digital Pathology 101 – Dr. Aleks’s book, referenced in the broader discussion of patient and pathologist education. Michigan Medicine breast pathology clinic – launched in 2023 as a patient-facing breast pathology clinic model. ASCP pathology clinic certification workshop – national workshop co-developed to help institutions build pathology clinics. 21st Century Cures Act – legal framework behind near real-time patient access to pathology reports and related health data. MyPathologyReport.ca – patient-friendly pathology education resource reviewed with patient advocate involvement. American Cancer Society Reach to Recovery – support resource mentioned for breast cancer patients. Scanslated – patient-friendly report interface discussed as part of a future-facing model for ...
    Mehr anzeigen Weniger anzeigen
    1 Std. und 13 Min.
  • 235: From Cytology to Omics: Where Pathology AI Gets Harder

    235: From Cytology to Omics: Where Pathology AI Gets Harder
    May 12 2026

    Send us Fan Mail

    DigiPath Digest #45 asks a practical question: can AI in pathology move from correlation to real clinical use? In this episode, I review four papers that push on that question from different angles: computational pathology moving toward morphology-driven molecular inference, the current state of digital cytopathology and AI, multi-omics and precision oncology in hepatocellular carcinoma, and AI literacy in veterinary education. What ties them together is not model performance alone. It is the harder question of validation, workflow fit, quantitative use, ethics, and human oversight.

    In the first paper, I talk about computational pathology as more than pattern recognition. The focus is on morphology-driven molecular inference, digital biomarkers, and why spatial omics matters as biological ground truth. I also discuss why continuous quantitative scoring is more useful than forcing biology into rough scoring buckets.

    The second paper focuses on digital cytopathology. Cytology was early for FDA-cleared AI in cervical screening, but non-gynecologic cytology is still much harder to digitize because of specimen variability and workflow complexity. I also cover telecytology, rapid onsite evaluation, automation, and quality control.

    The third paper looks at hepatocellular carcinoma and AI-driven precision oncology. This part is about using AI and machine learning to integrate genomics, transcriptomics, proteomics, metabolomics, radiomics, and pathology to support biomarker discovery, tumor microenvironment analysis, and treatment stratification.

    The fourth paper may be the most broadly useful. It proposes an AI literacy curriculum for veterinary education that covers AI fundamentals, machine learning evaluation, LLMs, ethics, liability, and academic integrity. I think that matters far beyond veterinary medicine, because if clinicians are expected to use AI tools responsibly, AI literacy cannot stay optional.

    Highlights
    00:01 Welcome and overview of the four papers
    03:02 Computational pathology and morphology-driven molecular inference
    11:01 Digital cytopathology, telecytology, and QC
    20:47 AI/ML in hepatocellular carcinoma precision oncology
    31:04 AI literacy in veterinary education
    47:42 Final takeaways and Digital Pathology 101 update

    Resources

    1. Computational Pathology as a Mechanistic Discipline: From Morphology to Molecular Data
      https://pubmed.ncbi.nlm.nih.gov/42052846/

    2. Advances in Digital Cytopathology and Artificial Intelligence Applications
      https://pubmed.ncbi.nlm.nih.gov/42046894/

    3. Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology
      https://pubmed.ncbi.nlm.nih.gov/42065059/

    4. Curriculum Framework for Artificial Intelligence Literacy in Veterinary Education
      Front Vet Sci. 2026;13:1801756

    Support the show

    Get the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    33 Min.
  • 234: Quality, Teaching, and AI: A Practical Shift in Pathology

    234: Quality, Teaching, and AI: A Practical Shift in Pathology
    Apr 25 2026

    Send us Fan Mail

    Where is AI in pathology actually becoming useful right now? In this episode of DigiPath Digest, I review 4 new PubMed papers across digital pathology, whole slide imaging (WSI), computational pathology, medical education, forensic pathology, and breast cancer AI. We look at a deep learning tool for coronary artery stenosis measurement in forensic autopsies, an AI-powered digital pathology model for renal pathology education, an open-source quality control tool for prostate biopsy whole slide images, and a breast cancer stage prediction model built for resource-constrained settings using low-magnification H&E slides. I also share updates on the upcoming second edition of Digital Pathology 101 and the decision to make AI paper summaries public on the podcast feed to help busy pathology professionals stay current.

    Highlights

    [01:28] Update on the upcoming second edition of Digital Pathology 101 and the release of public AI paper summaries for faster literature review.

    [05:22] Paper 1: Deep learning for coronary artery stenosis evaluation in forensic autopsies using whole slide imaging. Why objective stenosis measurement matters, how the model outperformed visual estimates, and why this could affect adoption in forensic pathology.

    [15:18] Paper 2: AI-powered digital pathology with case-based teaching in renal education. A practical discussion on annotated digital slides, flipped classroom learning, and how digital pathology can improve pathology education and diagnostic reasoning.

    [21:34] Paper 3: Open-source AI for quantitative quality control in prostate biopsy whole slide images. Why WSI quality control matters, what PathProfiler measures, and how automated QC can support remote pathology workflows.

    [32:38] Paper 4: Breast cancer stage prediction from H&E whole slide images in resource-constrained settings. A look at low-magnification AI, vision transformers, and what moderate performance can still mean when access to advanced testing is limited.

    [45:06] Closing thoughts, invitation to vote for future AI paper summaries, and a final reminder to download Digital Pathology 101.

    Resources
    Paper 1: Development of a deep learning-based tool for coronary artery stenosis evaluation in forensic autopsies using whole slide imaging
    PubMed: https://pubmed.ncbi.nlm.nih.gov/41998396/

    Paper 2: Integrating AI-Powered Digital Pathology With Case-Based Teaching: A Novel Paradigm for Renal Education in Medical School
    PubMed: https://pubmed.ncbi.nlm.nih.gov/41995002/

    Paper 3: Application of an open-source AI tool for quantitative quality control in whole slide images of prostate needle core biopsies - a retrospective study
    PubMed: https://pubmed.ncbi.nlm.nih.gov/41994924/

    Paper 4: Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings
    PubMed: https://pubmed.ncbi.nlm.nih.gov/41993946/

    Support the show

    Get the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    36 Min.
  • 233: AI-Driven Breast Cancer Staging in Resource-Constrained Settings

    233: AI-Driven Breast Cancer Staging in Resource-Constrained Settings
    Apr 24 2026

    Send us Fan Mail

    Paper Discussed in this Episode:

    Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings. Bedőházi Z, Biricz A, Kilim O, et al. Journal of Pathology Informatics 21 (2026) 100644.

    Episode Summary:

    Welcome back, Trailblazers! In this Journal Club deep dive of the Digital Pathology Podcast, we flip the core assumption of microscopic precision on its head. Can an AI accurately predict pathological breast cancer stages (pTNM I-III) from a blurry, high-altitude 2.5x magnification snapshot? We explore a 2026 study that strips away standard high-resolution data to build a highly efficient, resource-aware AI diagnostic tool for clinics lacking supercomputers. We unpack the math, the models, and a haunting revelation about what primary tumors can tell us about distant metastasis.

    In This Episode, We Cover:

    • The Compute Bottleneck: Why the digital pathology AI revolution is leaving resource-constrained clinics behind, and how dropping from the standard 40x to 2.5x magnification slashes image patch extraction by 256 times, bypassing massive hardware and server requirements.

    • The "Airplane View": How the AI compensates for the loss of microscopic cellular details (like mitosis or cellular atypia) by relying on macroscopic features, identifying disease through overall tumor growth patterns and broad architectural disruption.

    • Vision Transformers & "Puzzle Bags": Why the UNI foundation model—a vision transformer fine-tuned on the BRACS dataset—outperforms older convolutional networks (like ResNet-50) by mapping long-range spatial dependencies across the entire image patch simultaneously. Plus, how Multiple Instance Learning (MIL) acts as a targeted "puzzle bag," mathematically weighting critical cancer data and ignoring irrelevant background noise.

    • The Real-World Stress Test: The model's solid performance on the internal Semmelweis dataset versus the massive external Nightingale cohort, where unsupervised data cleaning with t-SNE and DBSCAN clustering automatically deleted garbage data. We also discuss the AI's struggle with the TCGA-BRCA dataset due to severe domain shift from heterogeneous tissue preparation, specifically the structural tissue damage caused by frozen sections.

    • The "Messy Middle" and Clinical Triage: The model's tendency to struggle with Stage II breast cancer and the critical clinical danger of under-staging advanced Stage III cancers. We discuss why this WSI-only baseline isn't replacing human pathologists, but rather serves as an automated "sorting hat" for incomplete medical records or a highly tunable "smoke detector" to route suspicious slides for immediate manual review.

    Key Takeaway:

    The AI successfully predicted overall cancer stage—which inherently includes distant lymph node metastasis—by looking only at the primary tumor's architectural disruption, without ever evaluating a single lymph node slide. This proves that vital systemic biological secrets are hiding in plain sight in the macroscopic view of standard H&E slides, offering a phenomenal proof-of-concept for global health equity in resource-constrained settings

    Support the show

    Get the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    21 Min.
  • 232: AI and Digital Pathology in Case-Based Renal Education

    232: AI and Digital Pathology in Case-Based Renal Education
    Apr 22 2026

    Send us Fan Mail

    Paper Discussed in this Episode:

    Integrating AI-Powered Digital Pathology With Case-Based Teaching: A Novel Paradigm for Renal Education in Medical School. Zhou H, Cui L. Clin Teach 2026; 23(3):e70421. doi: 10.1111/tct.70421.

    Episode Summary: In this journal club episode tailored for healthcare trailblazers, we explore a massive paradigm shift in medical education. We examine a 2026 perspective article that uses the notoriously complex field of renal pathology as a stress test for a brand-new teaching model. Moving away from dark lecture halls and static, perfect images, we discuss what happens when artificial intelligence is actively combined with flipped classrooms, fundamentally redefining what it means to be a competent physician in the digital age.

    In This Episode, We Cover:

    • The "Bottleneck" of Renal Pathology: Why the kidney is the ultimate teaching hurdle. Students must translate the dense, flattened 2D reality of an H&E stain into an understanding of a patient's complex systemic autoimmune response.

    • The Danger of the "Curated Reality": Why traditional teaching methods that rely on textbook-perfect, heavily curated slides create "brittle" mental models. When students finally encounter messy, real-world biopsies with overlapping, ambiguous pathologies, the traditional educational foundation falls apart.

    • The "Spell Checker" for Histopathology: How collaborative AI elevates Whole Slide Imaging (WSI) beyond just high-resolution screens. The AI acts as a concurrent guide, using pixel-level pattern recognition to highlight regions of interest simultaneously and simulate the complex reasoning process of an expert pathologist.

    • The Case-Based Flipped Classroom (CBFC): The pedagogical engine that anchors these AI tools in clinical reality. Instead of passive lectures, students are handed the "detective's case file" beforehand to actively interrogate annotated slides, synthesizing diverse data streams to defend diagnoses in collaborative groups.

    • Redefining Medical Competence (The "Clinical Editor"): Why the new bottleneck in medical education isn't memorization—it's critical appraisal. We discuss the necessity of teaching "digital literacy," training students to skeptically manage AI, recognize its blind spots (like confusing a physical tissue fold for an abnormality), and actively audit the algorithm against the messy human reality of the patient.

    • The Impending Culture Collision: A look at the fascinating future where freshly minted, AI-native residents enter a legacy clinical workforce still transitioning away from physical glass slides, potentially reversing traditional medical hierarchies in the hospital.

    Key Takeaway: The goal of modern medical education is no longer just memorizing histological patterns, as that heavy lifting is being outsourced to algorithms. By fusing AI-powered digital pathology with the necessary friction of case-based learning, we are training a new generation of diagnosticians to view AI not as a crutch, but as a powerful collaborative tool that must be thoughtfully scrutinized and audited for safe patient care

    Support the show

    Get the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    18 Min.
  • 231: The Future of Bone Marrow Biopsy: Omics and AI Integration

    231: The Future of Bone Marrow Biopsy: Omics and AI Integration
    Apr 20 2026

    Send us Fan Mail

    Paper Discussed in this Episode: Advancements in bone marrow biopsy: the role of omics and artificial intelligence in hematologic diagnostics. Maryam Alwahaibi and Nasar Alwahaibi. Front. Med. 2026; 13:1772478.

    Episode Summary: In this journal club deep dive, we explore a paradigm shift in hematopathology, moving from 19th-century visual assessments to the cutting edge of precision medicine. We examine a 2026 review that unpacks how combining artificial intelligence with multi-omics technologies is transforming the traditional bone marrow biopsy from a static, subjective snapshot into a live, interactive, predictive 3D map. We ask: What happens when deep learning can predict underlying genetic mutations just by analyzing the visual shape and texture of a cell?.

    In This Episode, We Cover:

    The Breaking Point of Traditional Diagnostics: Why the 150-year-old gold standard of H&E staining and human visual assessment is hitting a biological and operational wall, plagued by subjectivity, high variability, and observer fatigue.

    The Multi-Omics Multiverse: Moving beyond standard genomics to unpack the complex biological machinery of the marrow, including:
    Epigenomics: The biological "switches," like DNA methylation, that control cell fate and can kick off malignant transformation without altering the underlying DNA sequence.
    Lipidomics: How cellular fats form specialized signaling rafts that actively remodel the marrow's communication network.
    Microbiomics (The Gut-Marrow Axis): How systemic inflammation driven by gut dysbiosis acts like a massive "traffic jam" that indirectly disrupts local bone marrow homeostasis and blood cell production.

    AI as the Ultimate Analytical Partner: How artificial intelligence serves as a bridge between physical tissue morphology and high-dimensional molecular data. We discuss AI tools like MarrowQuant for objective cellularity mapping and the Continuous Index of Fibrosis (CIF) that replaces clunky human guesswork with a granular, predictive metric.

    Predicting Genotype from Phenotype: The revolutionary capability of deep learning models to predict underlying genetic mutations (like TET2 or del 5q MDS) purely from the subvisual, spatial arrangement and shape of cells on a standard slide.

    Roadblocks and Solutions: Why this technology isn't universally adopted yet. We break down the "black box" problem of AI, the brittleness of algorithms in different clinical settings, and how innovations like Federated Learning and Explainable AI (using heat maps) are overcoming these hurdles.

    Key Takeaway: The integration of AI and multi-omics is redefining our understanding of bone marrow diseases. By uncovering invisible molecular machinery and objectively translating it through transparent algorithms, we are moving away from subjective human bottlenecks toward a highly personalized, predictive model of hematologic care.



    Support the show

    Get the "Digital Pathology 101" FREE E-book and join us!
    Mehr anzeigen Weniger anzeigen
    21 Min.